ACME UNITED CORP - 10-Q Summary (Period Ended June 30, 1996)
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 1996, and the six-month period ended June 30, 1996. ACME United Corporation operates in domestic consumer, medical, and foreign markets. The reporting period was significantly impacted by the divestiture of its Altenbach subsidiary in Germany and ongoing restructuring efforts, including the closure of manufacturing and warehouse operations in Bridgeport, Connecticut.
Key Financial Metrics
| Metric | Q2 1996 | Q2 1995 | YTD 1996 | YTD 1995 |
|---|---|---|---|---|
| Net Sales ($000s) | $12,782 | $14,470 | $24,822 | $27,368 |
| Gross Profit Margin | 20.3% | 28.9% | 22.2% | 28.5% |
| Net Income (Loss) ($000s) | $(1,239) | $242 | $(2,055) | $174 |
| EPS (Diluted) | $(0.37) | $0.07 | $(0.62) | $0.05 |
| Cash and Equivalents ($000s) | $114 | $353 | $114 | $353 |
| Working Capital ($000s) | $12,923 | $15,975 | $12,923 | $15,975 |
| Total Debt ($000s) | $18,340 | $22,196 | $18,340 | $22,196 |
Note: Total Debt calculated as Notes payable due within one year ($4,248) plus Long term debt ($14,092). Prior year debt figures derived from text stating a $3,856,000 decrease from June 30, 1995 levels.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 11.7% in Q2 and 9.3% YTD compared to 1995. Approximately $975,000 of the Q2 decline and $1,221,000 of the YTD decline is attributed to the sale of the Altenbach business.
- Margin Compression: Gross profit margins contracted significantly (20.3% vs 28.9% in Q2) due to excess manufacturing capacity, restructuring costs, and reduced production volumes to align inventory with sales.
- Profitability: The company swung from a net profit in 1995 to a net loss in 1996. Q2 1996 included $608,000 in restructuring costs for the Bridgeport closure and $124,000 in severance costs.
- Debt Reduction: Total company debt decreased by $3,856,000 compared to June 30, 1995, driven by inventory reduction and cash generation.
Outlook, Risks, and Management Commentary
- Restructuring Progress: The Bridgeport manufacturing plant closure was completed four months ahead of schedule. Operations are transferring to a lower-cost facility in Fremont, North Carolina. The Bridgeport warehouse closure is scheduled for September 9, 1996.
- Liquidity and Covenants: The company was in default of one provision of its domestic revolving credit line as of June 30, 1996, but obtained a waiver from the lender. The $13 million revolving line expires in May 1998, with $12.19 million available at period end.
- Future Funding: Management expects future debt reduction and capital expenditures to be funded by inventory reduction and operating cash flow.
- Market Conditions: Domestic consumer sales were flat in Q2 due to ordering delays and competitive pricing in school sales, though first aid products showed growth. Medical product sales declined due to volume drops in the low-margin custom tray market.
Investor Verification Checklist
- Verify the status of the waiver obtained for the domestic revolving credit line default and any ongoing covenant compliance risks.
- Confirm the timeline and cost savings realization from the transition of manufacturing to the Fremont, North Carolina facility.
- Monitor inventory levels to ensure the projected cash generation from inventory reduction is achieved without further margin erosion.
- Assess the impact of the Altenbach divestiture on long-term foreign revenue streams and whether the $960,000 proceeds were fully realized.
- Review the specific provisions of the credit agreement that were in default to understand potential future triggers.